INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP)
申请人:Merck & Co., Inc.
公开号:EP2064204A1
公开(公告)日:2009-06-03
[EN] INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP)<br/>[FR] INHIBITEURS DE LA PROTÉINE D'ACTIVATION DE 5-LIPOXYGÉNASE (FLAP)
申请人:MERCK & CO INC
公开号:WO2008030369A1
公开(公告)日:2008-03-13
[EN] The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. [FR] La présente invention concerne des composés représentés par la Formule I qui sont des inhibiteurs d'une protéine activant la 5-lipoxygénase. Les composés représentés par la Formule (I) sont utiles en tant qu'agents anti-athérosclérotiques, anti-asthmatiques, anti-allergiques, anti-inflammatoires et cytoprotecteurs.
Traceless solid phase synthesis of 2-substituted pyrimidines using an ‘off-the-shelf’ chlorogermane-functionalised resin
作者:Alan C. Spivey、Ratnasothy Srikaran、Christopher M. Diaper、David J. Turner
DOI:10.1039/b303064d
日期:——
The parallel solid phase synthesis of an 18-member library of 2-substituted pyrimidines is described using a chlorogermane-functionalised resin. The success of the key Pinner-type condensations between a resin-bound enaminone and an array of amidine hydrochlorides highlights the stability of arylgermane linkers (cf. arylsilanes) towards strongly basic/nucleophilic conditions.